To study the effect of two Ayurveda medicines in patients with excessive menstrual bleeding
Phase 2
- Conditions
- Health Condition 1: null- Dysfunctional uterine bleeding
- Registration Number
- CTRI/2018/04/013081
- Lead Sponsor
- ational institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients complaining of Asrigdara as a cardinal symptom.
1.Heavy menstrual bleeding (amount >80ml) or
2.Prolonged menstrual bleeding (duration >7 days) or
3.Inter menstrual bleeding or
4.Frequent menstrual cycle (interval < 21 days)
Exclusion Criteria
1.Pregnant women.
2.Patients having bleeding due to abortion.
3.Patients having bleeding after menopause.
4.Patients having coagulation disorders.
5.Any type of malignancy.
6.Patients having STIs.
7.Patients having systemic diseases.
8.Patients having bleeding due to uterine or pelvic pathology
9.Patients using IUCD.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in symptoms and signs of dysfunctional uterine bleedingTimepoint: 3 months
- Secondary Outcome Measures
Name Time Method Restoration of normal menstrual cycle i.e amount and intervalTimepoint: 6 months